NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on Wednesday, May 11.
| Wednesday, May 11th at 4:30 PM ET | |
| Domestic: | 888-506-0062 |
| International: | 973-528-0011 |
| Conference ID: | 728427 |
| Webcast: | https://www.webcaster4.com/Webcast/Page/2879/45416 |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com
Exam registration for Certified Global Nurse - Rehabilitation (CGN-R) to open in July, handbook available…
Revolutionizing Healthcare: VMeDx Launches HIPAA-Compliant Virtual Medical Assistants for Enhanced Efficiency and Patient CareNASHVILLE, TN…
Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)…
Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"),…
Charlotte, North Carolina--(Newsfile Corp. - June 27, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
Ranking includes factors such as diversity, culture, work-life balance, career opportunities CHICAGO, June 27, 2024…